| State-of-the-Art Management of Colorectal Cancer: Treatment Advances and Innovation PS Pathak, G Chan, DA Deming, CE Chee American Society of Clinical Oncology Educational Book 44 (3), e438466, 2024 | 8 | 2024 |
| Guillain Barré syndrome heralding the diagnosis of angioimmunoblastic T-cell lymphoma P Pathak, S Perimbeti, A Ames, AJ Moskowitz Leukemia & lymphoma, 2019 | 4 | 2019 |
| Cerebrovascular accidents among African American adults with sickle cell disease: a nationwide outcomes and trend analysis over two decades C Mrad, P Pathak, MS Abougergi, JA Glassberg, L Cytryn Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 4644 …, 2017 | 3 | 2017 |
| Relationship of tumor fraction in circulating tumor DNA (ctDNA) with prognosis in patients with metastatic pancreatic cancer. P Pathak, G Li, J Quintanilha, RB Keller, L Pasquina, J Thierauf, R Graf, ... Journal of Clinical Oncology 42 (3_suppl), 621-621, 2024 | 2 | 2024 |
| 661: severe mycoplasma pneumoniae infection presenting with status asthmaticus, ARDS, and thromboembolism J Salonia, P Pathak, V Modi, J Shapiro Critical Care Medicine 47 (1), 311, 2019 | 2 | 2019 |
| Small steps can lead to substantial breakthroughs: moving the therapeutic needle forward in pancreatic cancer P Pathak, C Weekes, JY Wo The Lancet Oncology, 2024 | 1 | 2024 |
| Opioid Dependency Significantly Increases Complications and Mortality in Sickle Cell Disease SP Perimbeti, KY Hou, S Ramanathan, A Woodard, D Kyung, P Pathak, ... Blood, The Journal of the American Society of Hematology 132 (Supplement 1 …, 2018 | 1 | 2018 |
| Need of the hour—advancements in treatment of pancreatic cancer P Pathak, C Weekes AME Clinical Trials Review 2, 2024 | | 2024 |
| Abstract C073: FOLFIRINOX with Glycogen Synthase Kinase-3 Beta (GSK-3β) Inhibitor Elraglusib and Transforming Growth Factor-β (TGFβ) Inhibitor Losartan in Untreated Metastatic … P Pathak, E Lin, I Phillips, D Ting, C Weekes Cancer Research 84 (17_Supplement_2), C073-C073, 2024 | | 2024 |
| Feasibility, Safety, and Efficacy of Aggressive Multimodal Management of Elderly Patients With Pancreatic Ductal Adenocarcinoma G Qiao, ZV Fong, L Bolm, CF Del-Castillo, CR Ferrone, M Servin-Rojas, ... Annals of Surgery 280 (1), 118-125, 2024 | | 2024 |
| 514P Landscape of acquired resistance mechanisms in gastrointestinal cancers PS Pathak, H Barnes, A Hansen, B Caughey, SJ Klempner, A Parikh, ... Annals of Oncology 35, S205, 2024 | | 2024 |
| Hypofractionated Radiotherapy-Related Lymphopenia Is Associated With Worse Survival in Unresectable Intrahepatic Cholangiocarcinoma G Lee, DW Kim, AC Smart, NK Horick, CE Eyler, HJ Roberts, P Pathak, ... American Journal of Clinical Oncology, 10.1097, 2024 | | 2024 |
| SBRT with ipilimumab and nivolumab to metastatic MSS colorectal and pancreatic cancer: A pooled analysis of four prospective phase II trials. HJ Roberts, J Seidenberg, BY Yeap, JL Koenig, AR Parikh, JW Clark, ... Journal of Clinical Oncology 42 (3_suppl), 752-752, 2024 | | 2024 |
| The Sequencing Conundrum in Localized Pancreatic Adenocarcinoma—Progress or Passive Acceptance? P Pathak, CD Weekes, RT Shroff JAMA Oncology, 2024 | | 2024 |
| Investigation of immune repertoires in thymoma. P Pathak, M Cox, UP Dave, PJ Loehrer Journal of Clinical Oncology 38 (15_suppl), e21117-e21117, 2020 | | 2020 |
| Trends in mortality due to hypercalcemia in breast cancer. S Perimbeti, R Shrivastav, MD Stanchina, P Pathak, MR Rainone, ... Journal of Clinical Oncology 37 (15_suppl), e18252-e18252, 2019 | | 2019 |
| Transformed Indolent Lymphoma Outcomes Similar to De Novo Diffuse Large B-Cell Lymphoma after Autologous Hematopoietic Stem Cell Transplantation (AHCT), but Not Allogeneic HCT … P Pathak, GL Shah, E Tsyvkin, M Maloy, A Knezevic, SM Devlin, SA Giralt, ... Biology of Blood and Marrow Transplantation 24 (3), S255, 2018 | | 2018 |
